An assessment of norepinephrine mediated hypertrophy to apoptosis transition in cardiac cells: A signal for cell death

Chemico-Biological Interactions

Volumn 225, Issue , 2015, Pages 54-62

  Jain, Aditi ^a   Atale, Neha ^a   Kohli, Shrey ^b   Bhattacharya, Susinjan ^a   Sharma, Manish ^c   Rani, Vibha ^a  

^a JAYPEE INSTITUTE OF INFORMATION TECHNOLOGY   (India)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c DEFENCE INSTITUTE OF PHYSIOLOGY AND ALLIED SCIENCES   (India)

Author keywords

Apoptosis; Cardiomyocytes; Hypertrophy; Norepinephrine; Reactive oxygen species; Transition

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; CASPASE; DICHLORODIHYDROFLUORESCEIN DIACETATE; EOSIN; HEMATOXYLIN; MYOSIN HEAVY CHAIN BETA; NORADRENALIN; PROPIDIUM IODIDE; REACTIVE OXYGEN METABOLITE; RHODAMINE; TRYPAN BLUE; TUMOR NECROSIS FACTOR ALPHA; FORMAZAN; MTT FORMAZAN; RNA; TETRAZOLIUM; VENTRICULAR MYOSIN;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL STRESS; CELL STRUCTURE; CELL VIABILITY; CONCENTRATION (PARAMETERS); HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; MITOCHONDRIAL MEMBRANE POTENTIAL; MTT ASSAY; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; RAT; ANIMAL; CELL LINE; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; FLUORESCENCE MICROSCOPY; GENETICS; HEART MUSCLE; HYPERTROPHY; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; APOPTOSIS; CELL LINE; CELL SURVIVAL; FORMAZANS; HYPERTROPHY; IN SITU NICK-END LABELING; MICROSCOPY, FLUORESCENCE; MYOCARDIUM; MYOCYTES, CARDIAC; NOREPINEPHRINE; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TETRAZOLIUM SALTS; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR MYOSINS;

EID: 84916912034     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2014.11.017     Document Type: Article

References (40)

1. S. Fulda, A.M. Gorman, O. Hori, A. Samali, Cellular stress responses: cell survival and cell death, Int. J. Cell Biol. (2010), http://dx.doi.org/10.1155/2010/214074.
2. J. Jo, O. Gavrilova, S. Pack, W. Jou, S. Mullen, A.E. Sumner, S.W. Cushman, V. Periwal, Hypertrophy and/or hyperplasia: dynamics of adipose tissue growth, PLoS Comput. Biol. 5 (2009). doi:10.1371/journal.pcbi.1000324.
3. J.G. Dickhout, R.E. Carlisle, R.C. Austin, Interrelationship between cardiac hypertrophy, heart failure, and chronic kidney disease: endoplasmic reticulum stress as a mediator of pathogenesis, Circ. Res. 108 (2011) 629-642, http://dx.doi.org/10.1161/CIRCRESAHA.110.226803.
4. B.J. Maron, M.S. Maron, Hypertrophic cardiomyopathy, Lancet 381 (2013) 242-255, http://dx.doi.org/10.1016/S0140-6736(13)60922-8.
5. Q.M. Chen, V.C. Tu, S. Purdom, J. Wood, T. Dilley, Molecular mechanisms of cardiac hypertrophy induced by toxicants, Cardiovasc. Toxicol. 1 (2011) 267-283, http://dx.doi.org/10.1385/CT:1:4:267.
6. D.A. Morilak, G. Barrera, D.J. Echevarria, A.S. Garcia, A. Hernandez, S. Ma, C.O. Petre, Role of brain norepinephrine in the behavioral response to stress, Neuro-Psychopharmacol. Biol. Psychiatry 29 (2005) 1214-1224. doi:org/10.1016/j.pnpbp.2005.08.007.
7. C. Schroeder, J. Jordan, Norepinephrine transporter function and human cardiovascular disease, Am. J. Physiol. Heart C. 1 (2012) 303-314, http://dx.doi.org/10.1152/ajpheart.00492.2012.
8. W.S. Colucci, Molecular and cellular mechanisms of myocardial failure, Am. J. Cardiol. 2 (1997) 2-9.
9. R. Mobini, M. Fu, P.A. Jansson, C.H. Bergh, T.M. Scharin, F. Waagstein, B. Andersson, Influence of central inhibition of sympathetic nervous activity on myocardial metabolism in chronic heart failure: acute effects of the imidazoline I1-receptor agonist moxonidine, Clin. Sci. 110 (2006) 329-336, http://dx.doi.org/10.1042/CS20050037.
10. A.K. Sharma, S. Dhingra, N. Haper, P.K. Singal, Activation of apoptotic processes during transition from hypertrophy to heart failure in guinea pigs, Am. J. Physiol. Heart C. 293 (2007) 3H1384-H1390, http://dx.doi.org/10.1152/ajpheart.00553.2007.
11. N. Atale, M. Chakraborty, S. Mohanty, S. Bhattacharya, D. Nigam, M. Sharma, V. Rani, Cardioprotective role of syzygiumcumini against glucose-induced oxidative stress in H9C2 cardiac myocytes, Cardiovasc. Toxicol. (2013), http://dx.doi.org/10.1007/s12012-013-9207-1.
12. Z. Bian, H. Liao, Y. Zhang, Q. Wu, H. Zhou, Z. Yang, J. Fu, T. Wang, L. Yan, D. Shen, H. Li, Q. Tang, Never in mitosis gene a related kinase-6 attenuates pressure overload-induced activation of the protein kinase B pathway and cardiac hypertrophy, PLoS One 9 (4) (2014) e96095, http://dx.doi.org/10.1371/journal.pone.0096095.
13. N.E. Hahn, R.J. Musters, J.M. Fritz, P.J. Pagano, A.B. Vonk, W.J. Paulus, A.C. Rossum, C. Meischl, H.W. Niessen, P.A. Krijnen, Early NADPH oxidase-2 activation is crucial in phenylephrine-induced hypertrophy of H9c2 cells, Cell. Signal. 26 (9) (2014) 1818-1824, http://dx.doi.org/10.1016/j.cellsig.2014.04.018.
14. W.S. Hu, T.J. Ho, P. Pai, L.C. Chung, C.H. Kuo, S.H. Chang, F.J. Tsai, C.H. Tsai, Y.C. Jie, Y.M. Liou, C.Y. Huang, Gelsolin (GSN) induces cardiomyocyte hypertrophy and BNP expression via p38 signaling and GATA-4 transcriptional factor activation, Mol. Cell. Biochem. 390 (2014) 263-270, http://dx.doi.org/10.1007/s11010-014-1977-7.
15. S. Mishra, S. Chatterjee, Lactosylceramide promotes hypertrophy through ROS generation and activation of ERK1/2 in cardiomyocytes, Glycobiology 24 (6) (2014) 518-531, http://dx.doi.org/10.1093/glycob/cwu020.
16. S. Watkins, G. Borthwick, H. Arthur, The H9C2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro, In Vitro Cell. Dev. B 47 (2011) 125-131, http://dx.doi.org/10.1007/s11626-010-9368-1.
17. L. Yan, J.D. Zhang, B. Wang, Y.J. Lv, H. Jiang, G.L. Liu, Y. Qiao, M. Ren, X.F. Guo, Quercetin inhibits left ventricular hypertrophy in spontaneously hypertensive rats and inhibits angiotensin II-induced H9C2 cells hypertrophy by enhancing PPAR-γ expression and suppressing AP-1 activity, PLoS One 8 (9) (2013) e72548, http://dx.doi.org/10.1371/journal.pone.0072548 (Sep. 10).
18. B.N. Zordoky, A.O. El-Kadi, H9C2 cell line is a valuable in vitro model to study the drug metabolizing enzymes in the heart, J. Pharmacol. Toxicol. Methods 56 (2007) 317-322. doi:org/10.1016/j.vascn.2007.06.001.
19. M.K. Gupta, T.V. Neelakantan, S. Mishra, R.K. Tyagi, A. Dinda, S. Maulik, C.K. Mukhopadhyay, S.K. Goswami, An assessment of the role of reactive oxygen species and redox signaling in norepinephrine-induced apoptosis and hypertrophy of H9C2 cardiac myoblasts, Antioxid. Redox Sign. 8 (2006) 1081-1093, http://dx.doi.org/10.1089/ars.2006.8.1081.
20. J.A. Plumb, R. Milroy, S.B. Kaye, Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay, Cancer Res. 49 (1989) 4435-4440.
21. B.S. Cummings, R.G. Schnellmann, Measurement of cell death in mammalian cells, Curr. Protoc. Pharmacol. (2012), http://dx.doi.org/10.1002/0471141755 (Chapter 12, Unit 12.8).
22. T. Kuroiwa, G. Xi, Y. Hua, T.N. Nagaraja, J.D. Fenstermacher, R.F. Keep, Development of a rat model of photothrombotic ischemia and infarction within the caudoputamen, Stroke 40 (2009) 248-253, http://dx.doi.org/10.1161/STROKEAHA.108.527853.
23. J. Kapuscinski, B. Skoczylas, Fluorescent complexes of DNA with DAPI (40,6-diamidine-2-phenyl indoledihydrochloride) or DCI (40,6- dicarboxyamide-2-phenyl indole), Nucleic Acids Res. 5 (1978) 3775-3799.
24. C. Brana, C. Benham, L. Sundstrom, A method for characterising cell death in vitro by combining propidium iodide staining with immunohistochemistry, Brain Res. Protoc. 10 (2002) 109-114, http://dx.doi.org/10.1016/S1385-299X(02)00201-5.
25. D.G. Nicholls, Fluorescence measurement of mitochondrial membrane potential changes in cultured cells, Methods Mol. Biol. 10 (2012) 119-133, http://dx.doi.org/10.1007/978-1-61779-382-0-8.
26. V.J. Lincon, M.L. Walsh, L.B. Chen, Localization of mitochondria in living cells with rhodamine 123, Proc. Natl. Acad. Sci. U.S.A. 77 (1980) 990-994, http://dx.doi.org/10.1161/STROKEAHA.108.527853.
27. H. Wang, J.A. Joseph, Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader, Free Radical Biol. Med. 27 (1999) 612-616, http://dx.doi.org/10.1016/S0891-5849(99)00107-0.
28. M. Marotta, G. Martino, Sensitive spectrophotometric method for the quantitative estimation of collagen, Anal. Biochem. 150 (1985) 86-90. doi:org/10.1016/0003-2697(85)90443-9.
29. K. Fan, W.A. Nagle, Amyloid associated with elastin-staining laminar aggregates in the lungs of patients diagnosed with acute respiratory distress syndrome, BMC Pulm. Med. 2 (2002) 1-5, http://dx.doi.org/10.1186/1471-2466-2-5.
30. S. Ahuja, S. Kohli, S. Krishnan, D. Dogra, D. Sharma, V. Rani, Curcumin: a potential therapeutic polyphenol, prevents noradrenaline-induced hypertrophy in rat cardiac myocytes, J. Pharm. Pharmacol. 63 (2011) 1604-1612, http://dx.doi.org/10.1111/j.2042-7158.2011.01363.x.
31. S. Kohli, A. Chhabra, A. Jaiswal, Y. Rustagi, M. Sharma, V. Rani, Curcumin suppresses gelatinase B mediated norepinephrine induced stress in H9c2 cardiomyocytes, PLoS One 8 (2013) e76519, http://dx.doi.org/10.1371/journal.pone.0076519.
32. K.B. Lai, J.E. Sanderson, C.M. Yu, High dose norepinephrine induced apoptosis in cultured rat cardiac fibroblast, Int. J. Cardiol. 136 (2009) 33-39, http://dx.doi.org/10.1016/j.ijcard.2008.04.022.
33. Y.C. Fu, C.S. Chia, S.C. Yinc, B. Hwang, Y.T. Chiuc, S.L. Hsu, Norepinephrine induces apoptosis in neonatal rat cardiomyocytes through a reactive oxygen species-TNFa-caspase signaling pathway, Cardiovasc. Res. 62 (2004) 558-567, http://dx.doi.org/10.1016/j.cardiores.2004.01.039.
34. J.Y. Kim, Y.J. Kim, S. Lee, J.H. Park, BNip3 is a mediator of TNF-induced necrotic cell death, Apoptosis 16 (2011) 114-126, http://dx.doi.org/10.1007/s10495-010-0550-4.
35. H. Tsutsui, S. Kinugawa, S. Matsushima, Oxidative stress and heart failure, Am. J. Physiol. Heart C. 301 (2011) 2181-2190, http://dx.doi.org/10.1152/ajpheart.00554.
36. W.O. Carter, P.K. Narayanan, J.P. Robinson, Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells, J. Leukoc. Biol. 55 (1994) 253-258.
37. C. Putinski, M.A. Ghania, R. Stilesa, S. Brunettea, S.A. Dick, P.F. Fernandob, L.A. Megeney, Intrinsic-mediated caspase activation is essential for cardiomyocyte hypertrophy, PNAS (2013) E4079-E4087, http://dx.doi.org/10.1073/pnas.1315587110.
38. S.K.G. Koshi, H.K. Reddy, H.K. Shukla, Collagen cross-linking: new dimension to cardiac remodeling, Cardiovasc. Res. 57 (2003) 594-598, http://dx.doi.org/10.1016/S0008-6363(02)00877-5.
39. J.A. Rodriguez-Feo, J.P.G. Sluijter, D.P.V. Kleijn, G. Pasterkamp, Modulation of collagen turnover in cardiovascular disease, Curr. Pharm. Des. 11 (2005) 2501-2514, http://dx.doi.org/10.2174/1381612054367544.
40. N. Li, C. Zhou, Q. Duan, J. Lv, X. Fu, Y. Xia, D.W. Wang, β-AR blockers suppresses ER stress in cardiac hypertrophy and heart failure, PLoS One 6 (11) (2011) e27294, http://dx.doi.org/10.1371/journal.pone.0027294.